Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Thymoma × Bupivacaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 32 Breast Neoplasms 24 Lung Neoplasms 12 Pain 11 Agnosia 11 Leiomyoma 7 Pancreatic Neoplasms 5 Neoplasms 5 Prostatic Neoplasms 4 Colorectal Neoplasms 4 Rectal Neoplasms 3 Neuralgia 3 Hot Flashes 3 Colonic Neoplasms 3 Thyroid Nodule 2 Thyroid Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroma 2 Lymphedema 2 Liver Neoplasms 2 Kidney Neoplasms 2 Ileus 2 Hyperparathyroidism 2 Goiter 2 Digestive System Diseases 2 Chronic Pain 2 Breast Cancer Female 2 Brain Neoplasms 2 Adenomyosis 2 Abdominal Cancer 2

Interventions

Radiotherapy 5 Cisplatin 5 pembrolizumab 4 Cyclophosphamide 4 Thymectomy 3 Sunitinib 3 130-nm albumin-bound paclitaxel 3 selinexor 2 Pemetrexed 2 Methylprednisolone 2 Etoposide 2 Drug Therapy 2 Doxorubicin 2 Chemoradiotherapy 2 Carboplatin 2 zimberelimab 1 vorolanib 1 regorafenib 1 lenvatinib 1 epacadostat 1 envafolimab 1 bosutinib 1 amrubicin 1 Thoracic Surgery, Video-Assisted 1 TP protocol 1 Ramucirumab 1 Radiotherapy, Adjuvant 1 Radiosurgery 1 Radiofrequency Ablation 1 Radiation Dose Hypofractionation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06545409 2025-03-25

SPRATS

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Recruiting

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡